MEP47308A - Hfa-suspension formulation of an anhydrate - Google Patents
Hfa-suspension formulation of an anhydrateInfo
- Publication number
- MEP47308A MEP47308A MEP-473/08A MEP47308A MEP47308A ME P47308 A MEP47308 A ME P47308A ME P47308 A MEP47308 A ME P47308A ME P47308 A MEP47308 A ME P47308A
- Authority
- ME
- Montenegro
- Prior art keywords
- anhydrate
- hfa
- suspension formulation
- formulation
- suspension
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Pronalazak se odnosi na formulaciju, sa potisnim gasom, suspenzije, kristalnog anhidrata (1α,2β,4β,5α,7β)-7-[(hidroksidi-2-tienilacetil)oksi]-9,9-dimetil-3-oksa-9-azo-niatriciklo[3.3.1.02.4] nonan-bromida.The invention relates to the formulation, with propellant, of a suspension, of crystalline anhydrate (1α, 2β, 4β, 5α, 7β) -7 - [(hydroxides-2-thienylacetyl) oxy] -9,9-dimethyl-3-oxa-9 -azo-niatricyclo [3.3.1.02.4] nonan bromide.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10214264A DE10214264A1 (en) | 2002-03-28 | 2002-03-28 | HFA suspension formulations of an anhydrate |
PCT/EP2003/002899 WO2003082244A2 (en) | 2002-03-28 | 2003-03-20 | Hfa-suspension formulation of an anhydrate |
Publications (2)
Publication Number | Publication Date |
---|---|
MEP47308A true MEP47308A (en) | 2011-02-10 |
ME00246B ME00246B (en) | 2011-05-10 |
Family
ID=28050990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MEP-2008-473A ME00246B (en) | 2002-03-28 | 2003-03-20 | Hfa-suspension formulation of an anhydrate |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP1492498A2 (en) |
JP (1) | JP5147158B2 (en) |
KR (1) | KR101005717B1 (en) |
CN (1) | CN1642525A (en) |
AU (1) | AU2003221509B2 (en) |
BR (1) | BR0308709A (en) |
CA (1) | CA2479638C (en) |
DE (1) | DE10214264A1 (en) |
EA (1) | EA008610B1 (en) |
EC (1) | ECSP045322A (en) |
HR (1) | HRP20040890A2 (en) |
IL (1) | IL163696A0 (en) |
ME (1) | ME00246B (en) |
MX (1) | MXPA04009338A (en) |
NO (1) | NO20044004L (en) |
NZ (1) | NZ536030A (en) |
PL (1) | PL371295A1 (en) |
RS (1) | RS52481B (en) |
UA (1) | UA79776C2 (en) |
WO (1) | WO2003082244A2 (en) |
ZA (1) | ZA200405637B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2007144531A (en) * | 2005-05-02 | 2009-06-10 | БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) | NEW CRYSTAL FORMS OF THIOTROPYBROMIDE |
CA2606549A1 (en) * | 2005-05-02 | 2006-11-09 | Boehringer Ingelheim International Gmbh | Crystalline forms of tiotropium bromide |
AU2015201037C1 (en) * | 2009-05-29 | 2017-07-27 | Pearl Therapeutics, Inc. | Respiratory delivery of active agents |
EP2435024B1 (en) * | 2009-05-29 | 2016-07-06 | Pearl Therapeutics, Inc. | Compositions for respiratory delivery of active agents and associated methods and systems |
US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
KR102391332B1 (en) | 2013-03-15 | 2022-04-26 | 펄 테라퓨틱스 인코포레이티드 | Methods and systems for conditioning of particulate crystalline materials |
CN115252552A (en) * | 2016-09-19 | 2022-11-01 | 墨西哥氟石股份公司 | Pharmaceutical composition |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3931041C2 (en) * | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Esters of thienyl carboxylic acids with amino alcohols, their quaternization products, processes for their preparation and medicaments containing them |
ATE234604T1 (en) * | 1998-08-04 | 2003-04-15 | Jago Res Ag | MEDICAL AEROSOL FORMULATIONS |
GB0009606D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Therapeutic combinations |
GB0009592D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Respiratory combinations |
GB0009605D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Medicaments |
GB0009583D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Respiratory formulations |
DE10113366A1 (en) * | 2001-03-20 | 2002-09-26 | Boehringer Ingelheim Pharma | Medicament for treating inflammatory or obstructive respiratory diseases, e.g. asthma or chronic obstructive pulmonary disease, containing synergistic combination of anticholinergic agent and endothelin antagonist |
DE10111058A1 (en) * | 2001-03-08 | 2002-09-12 | Boehringer Ingelheim Pharma | New drug compositions based on anticholinergics and NK¶1¶ receptor antagonists |
ATE452639T1 (en) * | 2000-10-31 | 2010-01-15 | Boehringer Ingelheim Pharma | MEDICINAL COMPOSITIONS OF TIOTROPIUM SALTS AND EPINASTINE FOR THE THERAPY OF RESPIRATORY DISEASES |
-
2002
- 2002-03-28 DE DE10214264A patent/DE10214264A1/en not_active Withdrawn
-
2003
- 2003-03-20 UA UA20041008758A patent/UA79776C2/en unknown
- 2003-03-20 EP EP03717219A patent/EP1492498A2/en not_active Withdrawn
- 2003-03-20 RS YU86004A patent/RS52481B/en unknown
- 2003-03-20 EA EA200401159A patent/EA008610B1/en unknown
- 2003-03-20 WO PCT/EP2003/002899 patent/WO2003082244A2/en active Application Filing
- 2003-03-20 ME MEP-2008-473A patent/ME00246B/en unknown
- 2003-03-20 MX MXPA04009338A patent/MXPA04009338A/en active IP Right Grant
- 2003-03-20 KR KR1020047015174A patent/KR101005717B1/en active IP Right Grant
- 2003-03-20 PL PL03371295A patent/PL371295A1/en not_active Application Discontinuation
- 2003-03-20 NZ NZ536030A patent/NZ536030A/en not_active IP Right Cessation
- 2003-03-20 BR BR0308709-3A patent/BR0308709A/en active Pending
- 2003-03-20 CN CNA038072475A patent/CN1642525A/en active Pending
- 2003-03-20 IL IL16369603A patent/IL163696A0/en unknown
- 2003-03-20 CA CA2479638A patent/CA2479638C/en not_active Expired - Fee Related
- 2003-03-20 AU AU2003221509A patent/AU2003221509B2/en not_active Expired
- 2003-03-20 JP JP2003579782A patent/JP5147158B2/en not_active Expired - Lifetime
-
2004
- 2004-07-15 ZA ZA2004/05637A patent/ZA200405637B/en unknown
- 2004-09-23 NO NO20044004A patent/NO20044004L/en not_active Application Discontinuation
- 2004-09-27 HR HR20040890A patent/HRP20040890A2/en not_active Application Discontinuation
- 2004-09-28 EC EC2004005322A patent/ECSP045322A/en unknown
Also Published As
Publication number | Publication date |
---|---|
HRP20040890A2 (en) | 2005-06-30 |
YU86004A (en) | 2006-08-17 |
MXPA04009338A (en) | 2005-01-25 |
IL163696A0 (en) | 2005-12-18 |
JP5147158B2 (en) | 2013-02-20 |
CA2479638C (en) | 2011-01-04 |
EA200401159A1 (en) | 2005-04-28 |
CA2479638A1 (en) | 2003-10-09 |
NO20044004L (en) | 2004-10-05 |
JP2005527550A (en) | 2005-09-15 |
EA008610B1 (en) | 2007-06-29 |
WO2003082244A2 (en) | 2003-10-09 |
RS52481B (en) | 2013-02-28 |
AU2003221509B2 (en) | 2008-01-24 |
DE10214264A1 (en) | 2003-10-16 |
KR20040098022A (en) | 2004-11-18 |
UA79776C2 (en) | 2007-07-25 |
AU2003221509A1 (en) | 2003-10-13 |
NZ536030A (en) | 2006-07-28 |
WO2003082244A3 (en) | 2004-02-05 |
ECSP045322A (en) | 2005-01-28 |
KR101005717B1 (en) | 2011-01-05 |
CN1642525A (en) | 2005-07-20 |
PL371295A1 (en) | 2005-06-13 |
BR0308709A (en) | 2005-01-04 |
ZA200405637B (en) | 2005-07-27 |
ME00246B (en) | 2011-05-10 |
EP1492498A2 (en) | 2005-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200401142A1 (en) | MICRONIZED CRYSTALLINE TIOTROPYBROMID | |
EA200300666A1 (en) | METHOD OF OBTAINING OWNER OF ANTICHOLINERGIC ACTION OF THIOTROPYBROMID | |
MEP40008A (en) | Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament | |
MEP62008A (en) | Crystalline anticholinergic, method for its production, and use thereof in the production of a drug | |
CY1105543T1 (en) | ANTICHOLINERGIC CONTAINING HFA SUSPENSION PREPARATIONS | |
DK1401837T3 (en) | Purine derivatives as A2B adenosine receptor antagonists | |
DK1087960T3 (en) | Macrocyclic analogues and methods for their use and preparation | |
GT199900055A (en) | NEW DIETHYDROPYRIMIDINES2 HETEROCYCLICALLY SUBSTITUTED. | |
RS51436B (en) | Triazol tropane derivatives as ccr5 moudlators | |
AU2002229650A1 (en) | Method for producing the anticholinergic agent tiotropium bromide | |
ES2162614T1 (en) | FILM FORMATION COMPOSITIONS THAT INCLUDE MODIFIED ALMIDONES AND IOTA-CARRAGAENINE AND METHOD TO PRODUCE SOFT CAPSULES USING THE SAME. | |
MEP47308A (en) | Hfa-suspension formulation of an anhydrate | |
GB2380675A (en) | Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives | |
NZ228889A (en) | Fused tri- or tetracyclic heterocyclic compounds and pharmaceutical compositions | |
WO1993004042A1 (en) | Carbostyril derivative and platelet agglutination inhibitor | |
WO1994019343A3 (en) | Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof | |
PT1151360E (en) | REALIZATION PROCESS USING A GLOBAL POSITIONING SYSTEM | |
ECSP034921A (en) | CRYSTALLINE ANTI-POLYNERGIC, METHOD FOR PRODUCTION, AND USE OF THE SAME IN THE PRODUCTION OF A DRUG |